Last year at this time before RS there was still a hope for the FDA-decision PRO Genasense. But Genta was not able to deliver, thats why the stock price broke down at the end of last year.
This time Genta tries to promote Tesetaxel as a more promosing highlight. Good for the phantasy and risky as well, since not as far in the process as Genasense had been.
Interesting how they will sell Tesetaxel in the near future. After Re-Split!
News 
Market Data 
Discover 
